Early infections after autologous transplantation for haematological malignancies

Medical Oncology

Volumn 15, Issue 2, 1998, Pages 103-108

  Schiodt I ^a,b   Bergmann, O J ^a   Johnsen, H E ^a   Hansen, N E ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autologous transplantation; Bone marrow; Early infections; Haematological malignancies; Peripheral blood stem cells

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; BUSULFAN; CARMUSTINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DICLOXACILLIN; ETOPOSIDE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; KETOCONAZOLE; MELPHALAN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; VANCOMYCIN;

ACUTE LEUKEMIA; ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BACTEREMIA; FEMALE; FEVER; HOSPITALIZATION; HUMAN; INFECTION; INFECTIOUS COMPLICATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MYCOSIS; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA;

EID: 0031663861     PISSN: 07360118     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02989587     Document Type: Article

References (19)

1. Vose J, Kennedy BC, Bierman PJ, Kessinger A, Armitage JO. Long-term sequelae of autologous bone marrow or peripheral stem cell transplantation for lymphoid malignancies. Cancer 1992; 69: 784.
2. Peters WP et al. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high dose chemotherapy. Blood 1993; 81: 1709.
3. Faucher C et al. Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness. Bone Marrow Transplant 1994; 14: 895.
4. Pettengell R et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993; 82(12): 3770.
5. Bennett CL et al. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: Results from the University of Nebraska 1987 through 1991. J Clin Oncol 1995; 13: 969.
6. Liberti G, Pearce R, Taghipour G, Majolino I, Goldstone AH. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT registry data. Ann Oncol 1994; 5 (supplement 2): 151.
7. Mossad SB et al. Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 1996; 18: 265.
8. Schmitz N et al. Randomized trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 1996; 347: 353.
9. Bergmann OJ, Mogensen SC, Ellermann-Eriksen S, Ellegaard J. Acyclovir prophylaxis and fever during remission-induction therapy of patients with acute myeloid leukemia: A randomized, double-blind, placebo-controlled trial. J Clin Oncol 1997; 15: 2269.
10. Bergmann OJ. Oral infections and fever in immunocompromised patients with hematological malignancies. Eur J Clin Microbiol Infect Dis 1989; 8(3): 207.
11. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1996; 50: 163.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457.
13. Talbot GH, Cassileth PA, Paradiso L, Correa-Coronas R, Bond L. Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. Antimicrob Agents Chemother 1993; 37: 474.
14. EORTC International Antimicrobial Therapy Project Group. Reduction of fever and streptococcal bacteraemia in granulocytopenic patients with cancer. J Am Med Assoc 1994; 272: 1183.
15. Kern WV, Hay B, Kern P, Marre R, Arnold R. A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob Agents Chemother 1994; 38: 465.
16. Schaffner A, Schaffner M. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias. J Infect Dis 1995; 172: 1035.
17. Bergmann OJ, Ellermann-Eriksen S, Mogensen S, Ellegaard J. Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukemia: randomised, double-blind, placebo controlled trial. Br Med J 1995; 310: 1169.
18. D'Antonio D, Iacone A, Pierelli L, Bonfini T, and the Gruppo Italiano di Studio per la Manipolazione Cellulare in Ematologia. Patterns of recovery phase infection after autologous blood progenitor cell transplantation in patients with malignancies. Eur J Clin Microbiol Infect Dis 1995; 14: 552.
19. Kern W, Kurrle E, Schmeiser. Streptococcal bacteraemia in adult patients with leukemia undergoing aggressive chemotherapy: A review of 55 cases. Infection 1990; 18: 138.